probiotics

Probiotics and prevention: the €10 billion question for Europe

New IPA Europe analysis puts hard numbers on how evidence-based probiotic use could cut healthcare costs and boost productivity across the EU.

Bifidobacterium longum subsp. infantis M-63: shaping early-life gut microbiota and immunity in healthy full-term infants

Akari Hiraku, researcher at Innovative Research Institute, Morinaga Milk Industry Co., presented clinical data on Bifidobacterium longum subsp. infantis M-63, a probiotic strain with a remarkable capacity to utilize HMOs.

The story of three new probiotics: from infancy to discovery

Bifidobacterium breve 2TA, Lacticaseibacillus rhamnosus L13B, and Lactobacillus gasseri L6 are not just bacteria: they are witnesses to the intimate, ancestral dialogue between mothers, infants, and microbes.

Faecalibacterium prausnitzii: a microbiome-based candidate for IBD, C. diff and cancer

Philippe Langella, Research director at INRAE, talks about how F. prausnitzii could be a beneficial commensal.

Standardizing evidence on probiotics in acute gastroenteritis: why guidelines diverge and clinicians are confused

Yvan Vandenplas, Head of the Pediatric Hospital at the University Hospital Brussels, uses the example of probiotics in acute gastroenteritis to highlight how heterogeneous methodologies in evidence synthesis can lead…

Microbiota, immunity, and the environment: towards an integrated One Health approach

At the 13th Probiotics, Prebiotics and New Foods Congress, Silvia Turroni (University of Bologna) shares insights from the session “The Microbiome and One Health,” which explored how the microbiota bridges…

Microbiome modulation in menopause: a clinical guide for gynecologists

Download the instant book.

Microbiota and women’s health: emerging evidence and personalized perspectives

During the 2025 Probiotics, Prebiotics & New Food congress, it was presented the English edition of "Microbioma al femminile", a book dedicated to the intricate relationship between the microbiota and…

Innovating with probiotics: the case of Limosilactobacillus reuteri and the Black Queen hypothesis in strain discovery

Gianfranco Grompone, scientific director at BioGaia, explored innovative strategies for developing next-generation probiotics, with a focus on Limosilactobacillus reuteri DSM 17938. 

Synbiotic supplementation improves symptoms in patients with post-COVID-19 chronic fatigue syndrome: results from a randomized placebo‑controlled clinical trial

Taking the synbiotic mixture for three months appeared to boost the body’s metabolism and mitigates some of the main symptoms of post-COVID fatigue syndrome.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top